COVID-19 vaccination intention among people who use drugs in France in 2021: results from the international community-based research program EPIC.

IF 4 2区社会学 Q1 SUBSTANCE ABUSE

Harm Reduction Journal Pub Date : 2024-10-16 DOI:10.1186/s12954-024-01096-6

C Lacoux, V Villes, L Riegel, S Coulmain, N Lorente, S Eddine Derras, D Rojas Castro, P Roux, R M Delabre, D Michels

{"title":"COVID-19 vaccination intention among people who use drugs in France in 2021: results from the international community-based research program EPIC.","authors":"C Lacoux, V Villes, L Riegel, S Coulmain, N Lorente, S Eddine Derras, D Rojas Castro, P Roux, R M Delabre, D Michels","doi":"10.1186/s12954-024-01096-6","DOIUrl":null,"url":null,"abstract":"Background: COVID-19 vaccination is crucial to reduce the incidence of severe forms of the disease in the population. However, people who use drugs (PWUD) face structural and individual barriers to vaccination, and little is known about vaccination intention and factors associated with that intention among PWUD. This study aimed to estimate vaccination intention in PWUD and associated factors in the early stage of vaccination campaigns.Methods: We conducted cross-sectional study in France among PWUD, as part of the international EPIC program, a community-based research study coordinated by Coalition PLUS. It included 166 unvaccinated PWUD attending harm reduction centers. A questionnaire collected data on sociodemographic characteristics, COVID-19 related difficulties, and mental health, among other things. Multivariate logistic regression was used to identify factors associated with low vaccination intention.Results: Only 19% of participants reported strong intention to get vaccinated against COVID-19. Factors independently associated with low vaccination intention were younger age (aOR = 0.90, 95%CI = 0.85-0.95), lower education level (aOR = 2.67, 95% CI = 0.95-7.55), and unstable housing (aOR = 6.44, 95% CI = 1.59-40.34). The most-cited reasons for low intention were mistrust in COVID-19 vaccines (66.1%), fear of side effects (48.7%), and non-belief in vaccinations in general (25.2%).Conclusions: This study highlights the need for targeted COVID-19 information and interventions to increase vaccine uptake in PWUD, especially those living in precarity. Community-based interventions and targeted government assistance could play a crucial role in addressing vaccine hesitancy in this population, not only for COVID-19 but for future epidemics.","PeriodicalId":12922,"journal":{"name":"Harm Reduction Journal","volume":"21 1","pages":"184"},"PeriodicalIF":4.0000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11481597/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Harm Reduction Journal","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1186/s12954-024-01096-6","RegionNum":2,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}

引用次数: 0

Abstract

Background: COVID-19 vaccination is crucial to reduce the incidence of severe forms of the disease in the population. However, people who use drugs (PWUD) face structural and individual barriers to vaccination, and little is known about vaccination intention and factors associated with that intention among PWUD. This study aimed to estimate vaccination intention in PWUD and associated factors in the early stage of vaccination campaigns.

Methods: We conducted cross-sectional study in France among PWUD, as part of the international EPIC program, a community-based research study coordinated by Coalition PLUS. It included 166 unvaccinated PWUD attending harm reduction centers. A questionnaire collected data on sociodemographic characteristics, COVID-19 related difficulties, and mental health, among other things. Multivariate logistic regression was used to identify factors associated with low vaccination intention.

Results: Only 19% of participants reported strong intention to get vaccinated against COVID-19. Factors independently associated with low vaccination intention were younger age (aOR = 0.90, 95%CI = 0.85-0.95), lower education level (aOR = 2.67, 95% CI = 0.95-7.55), and unstable housing (aOR = 6.44, 95% CI = 1.59-40.34). The most-cited reasons for low intention were mistrust in COVID-19 vaccines (66.1%), fear of side effects (48.7%), and non-belief in vaccinations in general (25.2%).

Conclusions: This study highlights the need for targeted COVID-19 information and interventions to increase vaccine uptake in PWUD, especially those living in precarity. Community-based interventions and targeted government assistance could play a crucial role in addressing vaccine hesitancy in this population, not only for COVID-19 but for future epidemics.

查看原文本刊更多论文

2021 年法国吸毒者的 COVID-19 疫苗接种意向：国际社区研究计划 EPIC 的结果。

背景：接种 COVID-19 疫苗对于降低人口中严重形式疾病的发病率至关重要。然而，吸毒者（PWUD）在接种疫苗时面临着结构性和个体障碍，而且人们对吸毒者的接种意愿以及与接种意愿相关的因素知之甚少。本研究旨在估算吸毒人群在疫苗接种活动早期的接种意愿及相关因素：我们在法国对残疾人进行了横断面研究，这是国际 EPIC 计划的一部分，该计划是由 Coalition PLUS 协调的一项以社区为基础的研究。研究对象包括 166 名在减低伤害中心就诊的未接种疫苗的艾滋病感染者。调查问卷收集了有关社会人口特征、COVID-19 相关困难和心理健康等方面的数据。多变量逻辑回归用于确定与疫苗接种意愿低相关的因素：结果：只有 19% 的参与者表示有强烈意愿接种 COVID-19 疫苗。与接种意愿低独立相关的因素有年龄较小（aOR = 0.90，95%CI = 0.85-0.95）、教育水平较低（aOR = 2.67，95%CI = 0.95-7.55）和住房不稳定（aOR = 6.44，95%CI = 1.59-40.34）。接种意愿低的最主要原因是对 COVID-19 疫苗不信任（66.1%）、害怕副作用（48.7%）以及不相信疫苗接种（25.2%）：本研究强调了有必要提供有针对性的 COVID-19 信息和干预措施，以提高 PWUD 的疫苗接种率，尤其是那些生活不稳定的人群。以社区为基础的干预措施和有针对性的政府援助可在解决该人群的疫苗接种犹豫方面发挥关键作用，这不仅是为了应对 COVID-19，也是为了应对未来的流行病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Harm Reduction Journal Medicine-Public Health, Environmental and Occupational Health

CiteScore

5.90

自引率

9.10%

发文量

126

审稿时长

26 weeks

期刊介绍： Harm Reduction Journal is an Open Access, peer-reviewed, online journal whose focus is on the prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both drugs and drug policies. We define "harm reduction" as "policies and programs which aim to reduce the health, social, and economic costs of legal and illegal psychoactive drug use without necessarily reducing drug consumption". We are especially interested in studies of the evolving patterns of drug use around the world, their implications for the spread of HIV/AIDS and other blood-borne pathogens.